Clinical Centers

With over 25 years of experience, 3S Pharma is a Contract Research Organization (CRO) Group providing a complete range of clinical development and bio-analytical services.

We are here for you, in every stage of your drug development, from CFR protocol and CRF development, to final report.

3S PHARMA modern medical facilities

clinical centers

ROMANIA

3S Romania’s Phase I–IV Clinical Operations

  • GCP inspected (2012, 2014, 2015, 2021), located in Romania
  • Facilities equipped to accommodate study subjects for both short and extended confinement periods (up to 8–12 weeks)
  • Emergency capabilities available to support all clinical study requirements
  • AI-assisted bioanalytical laboratory, GLP certified since 2003, with more than 300 validated bioanalytical methods

MOLDOVA

The Clinical Centers located in Chisinau, Rep. Moldova were established in 1999 (one unit) and in 2011 the second unit, both of them in cooperation with public hospitals.

  • The facilities are fully equipped and technologized, with 86 beds and a large database of healthy volunteers and chronic disease in evidence patients. 
  • Both sites are focused on Phase I studies (especially BA/BE and other PK studies ex. interaction studies) and Phase II studies.
  • The clinical units are equipped with freezers (-20, -80 Celsius degrees), cooling centrifuges, thermostatic cabinets for study medication storage, UPS, fuel power generator, etc. Emergency departments available.

*In case of studies requiring a specific group of patients, several contacts with other hospitals are in place and new collaborations are continuously developed.

3S Pharma quick overview

100 MEMBERS

of staff insoved in clinical studies, of which more than half are University graduated scientists (medical doctors, pharmacists, biologists, etc.).

50+ FULL TIME EMPLOYEES

are insolved in bio-analytics, some of them with more than 25 years of experience while others being young, enthusiastic followers.

1500+ STUDIES

in EUROPE and USA as well as in Canada, New Zealand, UAE, Australia, Malaysia and Taiwan

OUR BIO-ANALYTICAL LABORATORY

is specialized in HPLC-MS/MS (high sensitivity instruments for small and large molecules) and Ligand Binding Assay

PUBLICATIONS

A sustained scientific activity is performed by our researchers as proved by a series of relevant publications in international peer reviewed journals and by the participation to public research projects in cooperation with other institutions (Universities, National Research Centers).

5 CONTINENTS

In all these years of activity, our companies have carried out more than 1500 studies for customers located in 5 continents and more than 30 countries (Germany, Italy, France, Greece, other EU countries and Canada, USA, India, etc.).

VALIDATION AND ACCREDITATION

International certified expertise

3S Pharma is a full-service Contract Research Organization (CRO) with internationally recognized capabilities in clinical pharmacology and bioanalysis.

The company operates state-of-the-art clinical research units in Romania and Moldova, which have been successfully inspected by regulatory authorities such as the U.S. Food and Drug Administration (FDA), as well as national agencies from France (ANSM), The Netherlands (CCMO), Germany (BfArM), Austria (AGES), Denmark (DKMA), and Romania (ANMDMR), often under the coordination of the European Medicines Agency (EMA).
View recent articles

These inspections confirm 3S Pharma’s full compliance with ICH-GCP guidelines and international regulatory requirements.

The organization’s extensive operational portfolio—comprising over 1,000 registered clinical trials globally—and its contribution to scientific literature further validate its role as a reliable and competent CRO partner for early-phase and late-phase development programs.

3 S Pharma ensures end-to-end solutions and support and continues to shape new approaches under international regulatory guidance.

Nevertheless, our researchers outstanding performance is also highlighted by a series of relevant publications in international peer reviewed journals and by the participation in public research projects in cooperation with other institutions (Universities, National Research Centers).
View recent articles
Logo 3s Pharma2 1